<p>
    Other Medications:&nbsp;
</p>
<figure class="table">
    <table class="table table-bordered">
        <tbody>
            <tr class="table-secondary">
                <td>
                    Medication&nbsp;
                </td>
                <td>
                    Indication(s)&nbsp;
                </td>
                <td>
                    Dose / Duration&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Vitamin K&nbsp;</strong>
                </td>
                <td>
                    High INR post-op with antibiotics or malnutrition&nbsp;
                </td>
                <td>
                    10 mg IV daily × 3 days&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Aspirin (ASA)&nbsp;</strong>
                </td>
                <td>
                    - Splenectomy- Short jump-graft- Colon cancer with isolated liver mets (low thrombosis risk: young patients, easy surgery)&nbsp;
                </td>
                <td>
                    81 mg PO daily × 3–6 months&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Anticoagulation&nbsp;</strong>
                </td>
                <td>
                    - Budd-Chiari syndrome- Pre-op portal vein thrombosis (PVT)- Long jump-graft- Colon cancer with isolated liver mets (high thrombosis risk: older patients, difficult/long surgery)&nbsp;
                </td>
                <td>
                    Heparin infusion POD 2 (no bolus) × 1 day → SC heparin × 2 weeks → oral anticoagulant (rivaroxaban 20 mg daily OR apixaban 5 mg BID) × 3–6 months&nbsp;
                </td>
            </tr>
            <tr>
                <td>
                    <strong>Pantoprazole&nbsp;</strong>
                </td>
                <td>
                    All post-transplant patients&nbsp;
                </td>
                <td>
                    40 mg PO daily&nbsp;
                </td>
            </tr>
        </tbody>
    </table>
</figure>